Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$9.70
+10.48%
Mkt Cap $733.25M
Analyst Ratings
Buy
2
Hold
4
Sell
2
Price Target (15 analysts)
$14.00
Range $14.00 – $14.00
Implied Upside
+44.3%
Consensus $14.00 vs current $9.70
NASDAQ·Healthcare·Biotechnology
$9.70
+10.48%
Mkt Cap $733.25M
Buy
2
Hold
4
Sell
2
Price Target (15 analysts)
$14.00
Range $14.00 – $14.00
+44.3%
Consensus $14.00 vs current $9.70